Showing of 1-10 from 1927 result
July 14, 2018, Saturday | International
Indivior on Friday said the restrictions of the previous restraining order remain in place, preventing Dr. Reddy's from selling or importing its generic buprenorphine/naloxone
July 11, 2018, Wednesday | Companies
Street is cautious as Mallinckrodt biz is declining amid enhanced scrutiny on opioid drugs
July 11, 2018, Wednesday | Companies
The two drugs, Gibtulio Met and Ajaduo, will be co-marketed simultaneously by Boehringer Ingelheim and Lupin across India under different brand names
June 29, 2018, Friday | International
The restraining order was extended for another 14 days on June 15 during which time the US court will consider the application and issue a ruling on the injunction
June 29, 2018, Friday | Companies
Analysts at Elara Capital say Ertapenem approval gives comfort to Aurobindo's ability to grow its US business in FY19, despite the high base
June 20, 2018, Wednesday | Markets
The stock up 3% at Rs 622 on the BSE in early morning trade and is 6.6% away from its 52-week high of Rs 663 touched on November 7, 2017.
June 20, 2018, Wednesday | Reuters
A decade and a half ago GE was the world's most valuable public company
June 18, 2018, Monday | Markets
Indivior stuck to its 2018 revenue guidance on Friday but said it would revisit the forecast if Dr Reddy's launches the cheaper drug
June 17, 2018, Sunday | Companies
The court has scheduled an expedited hearing of the preliminary injection for Thursday (June 28) and a ruling is expected soon after
June 16, 2018, Saturday | Companies
Dr Reddy's recently announced the launch of Buprenophine and Naloxone Sublingual Film, a generic equivalent of Suboxone
June 16, 2018, Saturday | Economy & Policy
Prime Minister Narendra Modi is expected to roll out the Ayushman Bharat scheme on August 15
June 14, 2018, Thursday | Current Affairs
Experts believe the move will have little impact given limited production of generic drugs and authority of doctors in prescribing medicines.
June 13, 2018, Wednesday | Current Affairs
Over 35% of the generic and branded drugs were purchased from private facilities across all survey sites
June 02, 2018, Saturday | Current Affairs
Zydus Cadila is a global pharmaceutical company that develops, manufactures and markets a broad range of healthcare therapies
May 22, 2018, Tuesday | Companies
Total income from operations stood at Rs 36.9797 billion. It was Rs 35.82 billion for the same period a year ago
May 07, 2018, Monday | Companies
Homegrown firms saw R&D spend, as percentage of sales, rise in past 5 years
March 31, 2018, Saturday | Companies
Teva launched the generic version of Irish firm Shire's Lialda in the US earlier this week
March 26, 2018, Monday | Companies
The product is the generic version of Aton Pharma Inc's Lodosyn tablets in the same strength
March 23, 2018, Friday | Companies
Given pricing pressure in the US on its generic portfolio, Sun Pharma has been focusing on bringing to the market its next growth vehicle in the form of speciality drugs
